Navigation Links
Two New Human Papilloma virus (HPV) vaccines to prevent cervical cancer

Cervical cancer is the second leading cause of female cancer mortality worldwide, with 288,000 deaths annually. About 510,000 cases are // reported each year, 80% of them in developing countries.

Two new vaccines are undergoing trial to prevent HPV infections, which causes cervical cancer. These vaccines must be given to girls before they are sexually active. The new vaccines are manufactured by GlaxoSmithkline against HPV 16 and 18 strains and the Merck Vaccine against HPV 16,18,6 and 11. These vaccines carry the L capsid protein and when given in 3 doses generate high levels of neutralizing antibodies.

Both the drugs are safe and show an efficacy of more than 90% in Phase I and II trials. These both vaccines are in their phase III trial and are expected to be in market in an other 2 years.

Studies are currently undergoing to find the duration and efficacy of the vaccine, its effect on menstrual cycle and the need for booster vaccine. Problems with the new vaccine are due to high cost, the dosages required are three injections and creating a cold chain for transport to rural areas. This vaccine should be modified to give protection against more HPV types and must be cheaper and easier to administer.

Experts say though this vaccine may be effective for prevention of infection a better promising approach for developing countries would be to undergo a cheaper screening test and visual inspection followed by prevention and treatment.


'"/>




Page: 1

Related medicine news :

1. Human Genome Project Achieves Technological Triumph
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Human gene number increases
4. Scientists found ancient Human Germ Killer
5. New standards for Human Research Safety
6. Human wasting disease linked to a gene
7. The Human Mad Cow Case
8. Human Growth Hormone Found To be Dangerous For Human Use
9. Human Antibody That Can Block SARS
10. Human immunity system can battle HIV.
11. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global law ... 21st Drug & Medical Device Litigation Conference , taking place in New York Dec. ... chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the Trial ...
(Date:12/2/2016)... ... , ... Advanced Inc., a leading provider of travel therapy and travel nursing ... as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously served as ... operational leadership experience to Advanced Inc. He began his career in finance at Ernst ...
(Date:12/2/2016)... ... ... With the number of pain management programs available for people suffering with constant ... works for them. When an inventor from Suisun City, Calif., was unsuccessful in finding ... it with others. , He developed a prototype for PRO GO MASSAGE to relieve ...
(Date:12/2/2016)... ... December 02, 2016 , ... CloudLIMS.com, a ... SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research and testing laboratories ... and disposal. The new version is a faster and a more efficient product, ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016  LifeVac, the revolutionary ... included in the Emergency Response Training and Support Services ... excited to have LifeVac become part of the ERTSS ... Founder and CEO of LifeVac. "Having an established network ... and effectively will help leverage our efforts to spread ...
(Date:12/2/2016)... India , December 2, 2016 ... report "In Vitro Diagnostics/IVD Market by Product (Instruments, ... Hematology), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) ... global market is valued at USD 60.22 Billion ... at a CAGR of 5.5% during the forecast ...
(Date:12/2/2016)... 2, 2016 In the first ever attempt ... those derived from C. sativa, the Hebrew University in ... Napoli Federico II , the Universita` del Piemonte Orientale ... critical, integrated and unified inventory of phytocannabinoids of different ... on the remarkable chemical and structural diversity of phytocannabinoids. ...
Breaking Medicine Technology: